Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Sales (2023 - 2025)

Historic Return on Sales for Iovance Biotherapeutics (IOVA) over the last 6 years, with Q3 2025 value amounting to 1.35%.

  • Iovance Biotherapeutics' Return on Sales rose 700.0% to 1.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.59%, marking a year-over-year increase of 29200.0%. This contributed to the annual value of 2.27% for FY2024, which is 3711700.0% up from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Return on Sales is 1.35%, which was up 700.0% from 1.86% recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Return on Sales registered a high of 1.07% during Q4 2024, and its lowest value of 447.5% during Q2 2023.
  • For the 3-year period, Iovance Biotherapeutics' Return on Sales averaged around 110.07%, with its median value being 2.74% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 4443800bps in 2024, then surged by 700bps in 2025.
  • Over the past 3 years, Iovance Biotherapeutics' Return on Sales (Quarter) stood at 241.41% in 2023, then surged by 100bps to 1.07% in 2024, then decreased by -27bps to 1.35% in 2025.
  • Its last three reported values are 1.35% in Q3 2025, 1.86% for Q2 2025, and 2.36% during Q1 2025.